Lantern Pharma Inc. (32) | Bonus & Incentive Agreements (2)
- Second Amended and Restated 2018 Equity Incentive Plan dated October 20, 2022 (Filed With SEC on March 20, 2023)
- Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on April 16, 2020)
